SCHEMBL7186301

SCHEMBL7186301

COc1ccc(C(C)(C)C)cc1C=CC(=O)c1ccc(C(=O)N(C)C)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.57
CAPN1 P07384 1/20 0.56
LMNA P02545 2/20 0.52
MAPT P10636 2/20 0.52
ATM Q13315 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
CYP1A1 P04798 6/20 0.51
CYP1B1 Q16678 6/20 0.51
PTPN1 P18031 3/20 0.51
DPP4 P27487 1/20 0.49
TNFRSF1A P19438 1/20 0.47
MEN1 O00255 1/20 0.47
MITF O75030 1/20 0.47
ALDH1A1 P00352 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
PAX8 Q06710 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7190005 0.89 ABCG2 (0.53) ABCG2CAPN1LMNAMAPTATM
SCHEMBL7178602 0.87 PTPN1 (0.44) ABCG2CAPN1LMNAMAPTATM
SCHEMBL7179055 0.87 LMNA (0.49) ABCG2CAPN1LMNAMAPTATM
SCHEMBL7186672 0.86 CYP1A1 (0.50) ABCG2CAPN1LMNAMAPTATM
SCHEMBL7190651 0.84 ABCG2 (0.61) ABCG2CAPN1LMNAMAPTATM
SCHEMBL7184624 0.83 ABCG2 (0.61) ABCG2CAPN1CYP1A1CYP1B1PTPN1
SCHEMBL7184619 0.83 ABCG2 (0.61) ABCG2CAPN1CYP1A1CYP1B1PTPN1
SCHEMBL9273105 0.82 ABCG2 (0.46) ABCG2CAPN1LMNAMAPTATM
SCHEMBL7192248 0.81 ABCG2 (0.55) ABCG2CAPN1CYP1A1CYP1B1PTPN1
SCHEMBL7192254 0.81 ABCG2 (0.55) ABCG2CAPN1CYP1A1CYP1B1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed